NAGY, Andrej, Jolana LIPOLDOVÁ, Miroslav NOVÁK and Radka ŠTĚPÁNOVÁ. Occurrence of implantable cardioverter-defibrillator therapy in clinical practice. Cor et Vasa. AMSTERDAM: ELSEVIER SCIENCE BV, 2017, vol. 59, No 3, p. "E215"-"E221", 7 pp. ISSN 0010-8650. Available from: https://dx.doi.org/10.1016/j.crvasa.2016.12.014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Occurrence of implantable cardioverter-defibrillator therapy in clinical practice
Authors NAGY, Andrej (703 Slovakia, guarantor, belonging to the institution), Jolana LIPOLDOVÁ (203 Czech Republic, belonging to the institution), Miroslav NOVÁK (203 Czech Republic, belonging to the institution) and Radka ŠTĚPÁNOVÁ (203 Czech Republic, belonging to the institution).
Edition Cor et Vasa, AMSTERDAM, ELSEVIER SCIENCE BV, 2017, 0010-8650.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/17:00098523
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.crvasa.2016.12.014
UT WoS 000410032200001
Keywords in English ICD; Ventricular fibrillation; Ventricular tachycardia; Remote monitoring; SCD predictors; Programmed ventricular stimulation
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/1/2021 11:29.
Abstract
The landmark trials MADIT II, SCD-HeFT, and COMPANION in 2002-2005 years have reported their positive results to sudden cardiac death reduction. Since that time the indications for the use of implantable cardioverter-defibrillators (ICDs) have substantially broadened. The occurrence of appropriate ICD therapy differs in the individual trials. We were retrospectively analyzing the occurrence of ventricular tachycardia/ventricular fibrillation (VT/VF) from ICD remote monitoring database (Biotronik Home Monitoring TM, www.biotronik-homemonitoring.com). No significant difference was found between subgroups divided by the implantation indication, the programmed ventricular stimulation, the aggressivity of programmed ventricular stimulation protocol, left ventricular ejection fraction, ICD types, percentage of right ventricular pacing, diabetes mellitus, renal dysfunction and gender. VT/VF occurred statistically significantly more often in patients with non-sustained VT on the preimplant Holter monitoring report in patients with primary preventive indication for postinfarction coronary artery disease but not in primary preventive indication for non-ischemic dilated cardiomyopathy. We observed higher VT/VF occurrence in patients with preimplant syncope or presyncope even higher than in patients after cardiopulmonary resuscitation. There was a visible trend for higher VT/VF occurrence in patients with positive programmed ventricular stimulation especially with less aggressive protocol and in patients with left ventricular ejection fraction of 30% and less. Authors found the preimplant nonsustained ventricular tachycardia (NSVT) on Holter monitoring as the only independent predictor of VT/VF occurrence. (C) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. zo.o. All rights reserved.
Links
LM2015090, research and development projectName: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 5/5/2024 06:43